• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Histamine: a potential cytoprotective agent to improve cancer therapy?

作者信息

Martinel Lamas D J, Nicoud M B, Sterle H A, Cremaschi G A, Medina V A

机构信息

Laboratory of Radioisotopes, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.

Laboratory of Cellular and Molecular Biology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), and the National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

出版信息

Cell Death Dis. 2015 Dec 31;6(12):e2029. doi: 10.1038/cddis.2015.378.

DOI:10.1038/cddis.2015.378
PMID:26720338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4720909/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14a/4720909/50b8a117239a/cddis2015378f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14a/4720909/50b8a117239a/cddis2015378f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14a/4720909/50b8a117239a/cddis2015378f1.jpg

相似文献

1
Histamine: a potential cytoprotective agent to improve cancer therapy?组胺：一种改善癌症治疗的潜在细胞保护剂？
Cell Death Dis. 2015 Dec 31;6(12):e2029. doi: 10.1038/cddis.2015.378.
2
Hepato and Cardiotoxicity of Chemotherapeutic Treatment Evaluated by Means of Small Animal Imaging.
Anticancer Agents Med Chem. 2017;17(3):359-364. doi: 10.2174/1871520616666151110130619.
3
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice.临床有效的 PARP 抑制剂 AG014699 可改善心脏毒性，但不能增强多柔比星的疗效，尽管它可改善小鼠的肿瘤灌注和辐射反应。
Mol Cancer Ther. 2011 Dec;10(12):2320-9. doi: 10.1158/1535-7163.MCT-11-0356. Epub 2011 Sep 16.
4
[The use of Cardioxan as a cardioprotective agent during antitumor chemotherapy].[在抗肿瘤化疗期间使用卡地氧嗪作为心脏保护剂]
Ter Arkh. 1994;66(7):54-6.
5
Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.抗肿瘤药物引发大鼠肥大细胞组胺的非免疫性释放：药物组合的影响
Cancer Chemother Pharmacol. 1992;30(6):487-90. doi: 10.1007/BF00685603.
6
[Cardioxan as a cardioprotector in antineoplastic chemotherapy].[抗癌新药乙磺半胱氨酸作为抗肿瘤化疗中的心脏保护剂]
Klin Med (Mosk). 1996;74(5):65-7.
7
Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.组胺联合美法仑在离体肢体灌注中的协同抗肿瘤活性：临床前研究
J Natl Cancer Inst. 2004 Nov 3;96(21):1603-10. doi: 10.1093/jnci/djh300.
8
Delayed administration of dexrazoxane provides cardioprotection against anthracyclines in breast cancer or acute myeloid leukemia.
J Clin Oncol. 1997 Oct;15(10):3293-5. doi: 10.1200/JCO.1997.15.10.3293.
9
Amelioration of doxorubicin cardiotoxicity by the bispiperazinedione ICRF-187 in women with advanced breast cancer: a preliminary report.双哌嗪二酮ICRF-187改善晚期乳腺癌女性患者阿霉素心脏毒性的初步报告。
Neoplasma. 1993;40(4):259-62.
10
A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer.一项关于ICRF-187预防乳腺癌女性中阿霉素累积诱导心脏毒性的前瞻性随机试验。
Cancer Treat Rev. 1990 Sep;17(2-3):161-3. doi: 10.1016/0305-7372(90)90041-d.

引用本文的文献

1
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.肥大细胞的基因变化及其在肥大细胞瘤预后和治疗中的意义。
Genes (Basel). 2024 Jan 22;15(1):137. doi: 10.3390/genes15010137.
2
Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer.负载组胺和紫杉醇的纳米胶束制剂作为改善乳腺癌化疗的新策略。
Int J Mol Sci. 2023 Feb 10;24(4):3546. doi: 10.3390/ijms24043546.
3
Cytoprotective Activity of Newly Synthesized 3-(Arylmethylamino)-6-Methyl-4-Phenylpyridin-2(1)-Ones Derivatives.

本文引用的文献

1
Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models.组胺对阿霉素诱导的动物模型肝、心毒性的选择性细胞保护作用。
Cell Death Discov. 2015 Dec 21;1:15059. doi: 10.1038/cddiscovery.2015.59. eCollection 2015.
2
Bioreducible Micelles with Endosomal Buffering and Multidrug Resistance-Reversing Function Enhance Anti-Tumor Efficacy of Doxorubicin.具有内体缓冲和多药耐药逆转功能的可生物还原胶束增强阿霉素的抗肿瘤疗效。
J Biomed Nanotechnol. 2015 Oct;11(10):1764-75. doi: 10.1166/jbn.2015.2004.
3
Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.
新型 3-(芳基甲基氨基)-6-甲基-4-苯基吡啶-2(1H)-酮衍生物的细胞保护活性。
Molecules. 2022 Aug 23;27(17):5362. doi: 10.3390/molecules27175362.
4
Mast Cells: A New Frontier for Cancer Immunotherapy.肥大细胞：癌症免疫治疗的新前沿。
Cells. 2021 May 21;10(6):1270. doi: 10.3390/cells10061270.
5
Effects of Genetic Variation on Urinary Small Molecule Signatures of Mice after Exposure to Ionizing Radiation: A Study of p53 Deficiency.基因变异对电离辐射暴露后小鼠尿液小分子特征的影响：p53基因缺失的研究
Metabolites. 2020 Jun 8;10(6):234. doi: 10.3390/metabo10060234.
6
Mast Cells May Differentially Regulate Growth of Lymphoid Neoplasms by Opposite Modulation of Histamine Receptors.肥大细胞可能通过对组胺受体的相反调节来差异性地调控淋巴肿瘤的生长。
Front Oncol. 2019 Nov 21;9:1280. doi: 10.3389/fonc.2019.01280. eCollection 2019.
7
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.组胺H4受体在癌症中的病理生理作用：治疗意义
Front Pharmacol. 2019 Jun 5;10:556. doi: 10.3389/fphar.2019.00556. eCollection 2019.
8
Spatially resolved metabolomics to discover tumor-associated metabolic alterations.基于代谢组学的空间分辨技术发现肿瘤相关代谢改变。
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):52-57. doi: 10.1073/pnas.1808950116. Epub 2018 Dec 17.
9
Histamine receptors and cancer pharmacology: an update.组胺受体与癌症药理学：最新进展。
Br J Pharmacol. 2020 Feb;177(3):516-538. doi: 10.1111/bph.14535. Epub 2018 Dec 13.
10
Histamine deficiency aggravates cardiac injury through miR-206/216b-Atg13 axis-mediated autophagic-dependant apoptosis.组氨酸缺乏通过 miR-206/216b-Atg13 轴介导向自噬依赖性凋亡加重心脏损伤。
Cell Death Dis. 2018 Jun 7;9(6):694. doi: 10.1038/s41419-018-0723-6.
组胺可减轻口腔癌前模型中硼中子俘获疗法引起的粘膜炎。
Oral Dis. 2015 Sep;21(6):770-7. doi: 10.1111/odi.12346. Epub 2015 Jun 8.
4
Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.组胺在体外和体内增强人乳腺癌对电离辐射的反应。
Cancer Biol Ther. 2015;16(1):137-48. doi: 10.4161/15384047.2014.987091.
5
Histamine H₄ receptors in the gastrointestinal tract.胃肠道中的组胺H₄受体
Br J Pharmacol. 2015 Mar;172(5):1165-78. doi: 10.1111/bph.12989. Epub 2015 Jan 12.
6
Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials.辐射诱导正常组织毒性的机制及其对未来临床试验的意义。
Radiat Oncol J. 2014 Sep;32(3):103-15. doi: 10.3857/roj.2014.32.3.103. Epub 2014 Sep 30.
7
Therapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.组胺 H₄ 受体激动剂在三阴性人乳腺癌实验模型中的治疗潜力。
Br J Pharmacol. 2013 Sep;170(1):188-99. doi: 10.1111/bph.12137.
8
Radioprotective potential of histamine on rat small intestine and uterus.组胺对大鼠小肠和子宫的放射防护潜力。
Eur J Histochem. 2012 Dec 18;56(4):e48. doi: 10.4081/ejh.2012.e48.
9
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.多柔比星诱导性心肌病：从分子机制到治疗策略。
J Mol Cell Cardiol. 2012 Jun;52(6):1213-25. doi: 10.1016/j.yjmcc.2012.03.006. Epub 2012 Mar 21.
10
Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation.组胺可预防电离辐射引起的颌下腺功能和形态改变。
Int J Radiat Biol. 2011 Mar;87(3):284-92. doi: 10.3109/09553002.2010.533247. Epub 2010 Dec 10.